Essential thrombocytosis transformed AML with TP53 mutations and its clinical implications
Abstract Essential thrombocytosis (ET) is a chronic myeloproliferative neoplasm. There is a rare possibility of its transformation from ET into acute myeloid leukemia (AML). While the TP53 mutation is a well-known risk factor for AML, limited research exists regarding ET patients who develop AML wit...
Saved in:
| Main Authors: | Yang Si, Jiyuan Wang, Brett D Hambly, Yuli Wang, Yanfang Zhang, Shisan Bao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01665-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Essential Thrombocytosis: A Rare Entity
by: Parimi Ram Shashank, et al.
Published: (2023-01-01) -
CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS
by: E. G. lisina, et al.
Published: (2017-10-01) -
Iron overload mediates cytarabine resistance in AML by inhibiting the TP53 signaling pathway
by: Jia Yan, et al.
Published: (2025-02-01) -
TP53-mutated MDS and AML: immune dysregulation, tumor microenvironment, and emerging therapeutic strategies
by: Marwah M. Albakri, et al.
Published: (2025-08-01) -
Essential Thrombocythemia Masquerading as Henoch–Schonlein Purpura in a 9-year-old Child
by: Palanisamy Sivamurukan, et al.
Published: (2020-01-01)